PT  - JOURNAL ARTICLE
AU  - Eng, Genghmun
TI  - Orthogonal Functions for Evaluating Social Distancing Impact on CoVID-19 Spread
AID  - 10.1101/2020.06.30.20143149
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.30.20143149
4099  - http://medrxiv.org/content/early/2020/07/03/2020.06.30.20143149.short
4100  - http://medrxiv.org/content/early/2020/07/03/2020.06.30.20143149.full
AB  - Early CoVID-19 growth often obeys: , with Ko = [(ln 2)/(tdbl)], where tdbl is the pandemic doubling time, prior to society-wide Social Distancing. Previously, we modeled Social Distancing with tdbl as a linear function of time, where N [t] 1 ≈ exp[+KA t/ (1+,γot)] is used here. Additional parameters besides {Ko, γo} are needed to better model different ρ[t] = dN [t]/dt shapes. Thus, a new Orthogonal Function Model [OFM] is developed here using these orthogonal function series: where N (Z) and Z[t] form an implicit N [t] N (Z[t]) function, giving: with Lm(Z) being the Laguerre Polynomials. At large MF values, nearly arbitrary functions for N [t] and ρ [t] = dN [t]/dt can be accommodated. How to determine {KA, γo} and the {gm; m = (0, +MF)} constants from any given N (Z) dataset is derived, with ρ [t] set by: The bing com USA CoVID-19 data was analyzed using MF = (0, 1, 2) in the OFM. All results agreed to within about 10 percent, showing model robustness. Averaging over all these predictions gives the following overall estimates for the number of USA CoVID-19 cases at the pandemic end: which compares the pre- and post-early May bing com revisions. The CoVID-19 pandemic in Italy was examined next. The MF = 2 limit was inadequate to model the Italy ρ [t] pandemic tail. Thus, regions with a quick CoVID-19 pandemic shutoff may have additional Social Distancing factors operating, beyond what can be easily modeled by just progressively lengthening pandemic doubling times (with 13 Figures).Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo External FundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No Human Subjects Involved In This Data Analysis. No IRB approval needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is in the public domain or was maintained by bing.com.